This Solicitation opportunity from Department Of Defense was posted on September 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DEXTROSE ORAL GEL

Closed

SPE2DP-26-T-5242Federal

Submission Closed09/30/2026, 01:00:00 PM EDT

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Antibodies Elution Kit Supplier (NSN 6550-01-346-4878)This subcontract involves the supply of finished Antibodies Elution Kits, identified by NSN 6550-01-346-4878, for prime contractors serving the Department of Defense Medical Supply Chain. The required kits must contain concentrated wash, eluting, and buffering solutions designed for the rapid acid elution of antibodies from red blood cells. All deliverables must strictly adhere to FDA regulations, MIL-STD-2073-1E packaging requirements, and Medical Marking Standard No. 1. The scope of work requires the delivery of two complete kits to Keesler AFB, with each kit maintaining a minimum shelf-life of one month. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Gabapentin Capsules SupplyThis subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Hypoallergenic Soft Tissue Massage CreamThis subcontract involves the supply of non-greasy, hypoallergenic soft tissue massage cream for prime contractors supporting the Medical Supply Chain Pharm FSA under the Department of Defense. The supplier must provide products that strictly adhere to FDA regulations and meet the specifications of NSN 6508017007944. To ensure product integrity, items must be stored in heated environments maintained at 40 degrees Fahrenheit or above. The contract requires the delivery of six 15 oz containers to Fort Polk, Louisiana, on a FOB Destination basis. All packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. This procurement falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Cleansing Solution ManufacturerThis subcontract involves the manufacture and supply of Povidone-Iodine Cleansing Solution for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The solution must be produced according to USP standards, featuring a 7.5% active ingredient and a shelf life of 36 months. The product is to be delivered in one-gallon bottles, which must include SDS and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200. Additionally, the manufacturer must ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 96665.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

This procurement involves the supply of Povidone-Iodine Cleansing Solution, USP, with a 7.5% active ingredient for external use. The product must be delivered in one-gallon bottles with a total shelf life of 36 months, ensuring at least 31 months remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies delivery to the USS Harpers Ferry and USS Carter Hall, with a required delivery timeline of 20 days and FOB Destination terms. The contractor must adhere to strict packaging and marking standards, utilizing Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be packaged according to TQ requirement IP025 and FED-STD-313, and suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels per 29 C.F.R. 1910.1200 prior to award. The contract is governed by various FAR and DFARS clauses, including requirements for safeguarding covered defense information, compliance with the Buy American Act, and the prohibition of covered defense telecommunications equipment. All payment requests must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0243

Solicitation SPE2DP-27-T-0243 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of lyophilized Varicella Virus Vaccine Live, identified by NSN 6505-01-413-1331. Each package consists of 10 single dose vials of live vaccine and 10 vials of diluent. The vaccine is a Type I Code K item with a non-extendable shelf life of 18 months, and it must have at least 15 months of shelf life remaining upon delivery to the government. The product must be drop shipped directly from the manufacturer and stored frozen between -50C and -15C. Delivery is required within 20 days ADO to a destination in Japan, with FOB and inspection/acceptance points set at the destination. Packaging must be commercial and comply with MIL-STD-2073-1E and Special Packaging Instructions MPPWN00001, while labeling must adhere to Medical Marking Standard No. 1B. The contract incorporates various FAR and DFARS clauses, including requirements for Wide Area Workflow for invoicing, Buy American Act compliance, and strict cybersecurity reporting under DFARS 252.204-7012. This FDA-regulated drug requires a referral to a product specialist for confirmation during the buying process.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0270

Solicitation SPE2DP-27-T-0270 is a Small Business Set-Aside procurement issued by the Defense Logistics Agency for the acquisition of 10 bottles of Gabapentin Capsules, 100 MG, in quantities of 100 per bottle. This FDA-regulated drug must be stored at 25C with permitted excursions between 15C and 30C per USP Controlled Room Temperature standards. The item has a non-extendable shelf life of 36 months. Delivery is required FOB Destination to a medical detachment in Washington, DC, with a required delivery date of November 12, 2026. The contract mandates commercial packaging and packing, requiring each unit to be in a sealed container to prevent damage, with shipping containers ensuring safe delivery. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity requirements, and strict prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

6505--Nitroglycerin Patches

Solicitation # 36E79727R0010

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Calcium Trisodium Pentetate (Ca-DTPA) Sterile InjectablesThis subcontract involves the supply of Calcium Trisodium Pentetate (Ca-DTPA) sterile injectables to prime contractors supporting medical countermeasure projects for the Government of Canada's Department of National Defence. The scope of work requires the manufacture and delivery of 750 to 1,250 sterile 5.0 mL ampoules, each containing between 1,000 mg and 1,055 mg of the active ingredient for intravenous injection. To be eligible, the provider must operate sterile pharmaceutical manufacturing facilities and hold valid marketing authorization from Health Canada, the US FDA, the EMA, or an EU member state. The contract is categorized under NAICS code 325412, with performance taking place in Canada. Responses to this opportunity are due by November 25, 2026.

Department of National Defence

POSTED

DEADLINE

Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Solicitation # W6369-27-A062

The Department of National Defence, through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, is seeking the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules to treat Canadian Armed Forces personnel exposed to radioactive contamination involving transuranic elements. The required product must be a sterile solution for intravenous injection containing 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule, with a minimum shelf-life of 36 months from the date of manufacture. To ensure consistency with existing stockpiles, the product must adhere to specific packaging and labelling requirements and hold valid marketing authorization from Health Canada, the FDA, the EMA, or an EU member state. The procurement is being conducted via an Advance Contract Award Notice, with Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG identified as the sole known supplier capable of meeting the technical and clinical requirements. The contract is anticipated to run from the award date until March 31, 2031, with an estimated total value of 47,500 CAD. The firm requirement consists of 750 ampoules delivered in three annual increments of 250, starting no later than March 1, 2027, and ending by March 1, 2029. Additionally, the contract includes an option for up to 500 more ampoules exercisable throughout the contract period. This procurement is subject to the Canadian Free Trade Agreement and is not subject to set-asides or the Procurement Strategy for Indigenous Business.

Department of National Defence

POSTED

DEADLINE

Pharmaceutical Grade Salicylic Acid SupplyThis subcontract involves the supply of high-purity, pharmaceutical-grade salicylic acid to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work encompasses the chemical synthesis and purification of the acid to ensure it meets strict pharmaceutical standards for topical medical applications. All deliverables must be accompanied by SDS documentation and hold USP or equivalent pharmaceutical grade certifications. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance of the contract is designated for FPO 09564. Interested parties should note the response deadline of November 16, 2026, for this bulk supply requirement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Solicitation SPE2DP-26-T-5242 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for Dextrose Oral Gel, specifically 15 gram packages of three, identified by NSN 6505014253168. The requirement specifies a total shelf life of 18 months, with at least 15 months remaining from the date of manufacture to the date of delivery. The product must be provided in squeeze tubes with twist-off tips and packaged in suitable sealed unit containers and commercial exterior shipping containers to ensure safe delivery. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The delivery is set as FOB Destination with a lead time of 20 days, destined for the USS TULSA (LCS-16). Inspection and acceptance will also occur at the destination per FAR 52.246-2. This procurement is regulated by the FDA and incorporates various federal and defense clauses, including safeguarding covered defense information and compliance with the Buy American Act and Berry Amendment. All quotes must be submitted via the DLA Internet Bid Board System (DIBBS), and payment processing is required through the Wide Area WorkFlow (WAWF) system.

General Info

DLA request for Dextrose Oral Gel delivery to USS TULSA via DIBBS.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLDG 4486 CAMP SWIFT ROAD, FORT DRUM, NY, 13602-5000, USA

Set-Aside

NONE

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedSep 24

Solicitation

Notice updatedSep 24

The notice description changed.

Response DeadlineSep 30

Deadline has passed

Submission Closed

09/30/2026, 01:00:00 PM EDT

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Timothy Mccauley

contact@example.gov

+1 (555) 000-0000

Full Description

DEXTROSE ORAL GEL
DEXTROSE ORAL GEL 15 GRAMS PACKAGE OF 3'S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
IN SQUEEZE TUBE WITH TWIST OFF TIP
1 PG = 3 EA
SHALL HAVE A SHELF LIFE OF 18 MONTHS. NOT LESS THAN 15 MONTHS SHALL HAVE
ELAPSED FROM DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE GOVERNMENT.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a
SPE2DP-26-T-5242
SECTION B
shelf life of 18 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION
OF THE MEDICAL MARKING STANDARD NO. 1
https://www.dla.mil/Logistics-Operations/Packaging/
PADAGIS US LLC 9MGE4 P/N NDC00574007030 TOPRAIL CHP LLC 8S2D8 P/N NDC72847021315
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018502067 0001 PG 1.000
NSN/MATERIAL:6505014253168
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-425-3168 Quantity: 1 PG Purchase Request: 7018502067QTY: 1 Delivery: 20 days ADO